Yali Zhou
Shanxi Agricultural University(CN)Central South University(CN)University of Electronic Science and Technology of China(CN)Guilin Medical University(CN)Changsha University(CN)Lanzhou University Second Hospital(CN)Io Therapeutics (United States)(US)303 Hospital of People's Liberation Army(CN)Lanzhou University(CN)Xinxiang Medical University(CN)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, CAR-T cell therapy research, Soybean genetics and cultivation, Lipid metabolism and biosynthesis, MicroRNA in disease regulation
Most-Cited Works
- → CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia(2021)264 cited
- → A negative feedback loop of transcription factors that controls stem cell pluripotency and self‐renewal(2006)238 cited
- → NCOA4-mediated ferritinophagy is involved in ionizing radiation-induced ferroptosis of intestinal epithelial cells(2022)196 cited
- → Exosomes Derived from Human Bone Marrow Mesenchymal Stem Cells Promote Tumor Growth Through Hedgehog Signaling Pathway(2017)190 cited
- → Preparation of 5-fluorouracil-loaded chitosan nanoparticles and study of the sustained release in vitro and in vivo(2017)186 cited
- → Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study(2022)